At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
New Amino Acid formula +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Controlled, Cross-over Study to Assess Hypoallergenicity of a New Amino-acid Based Infant Formula in Children With Cow's Milk Allergy
In Brief
A clinical study evaluating New Amino Acid formula and Commercially available Amino Acid Formula for Cow's Milk Allergy. Completed, enrolled 41 participants across 1 site.
Detailed Summary
This is a prospective, controlled, multi-country study to verifying the hypoallergenicity of the new amino acid-based formula in infants and children aged\< 12 years with documented cow's milk protein allergy (CMPA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCow's Milk Allergy
CountriesItaly
CollaboratorsOPBG Clinical & Research Services S.R.L.
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartApr 2015
First PostedApr 2015
Primary CompletionDec 2016
TodayJul 2026
First PostedApr 10, 2015
Enrollment StartApr 1, 2015
Primary CompletionDec 30, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.2 years ago
Interventions
New Amino Acid formulaother
Ordesa's Amino-Acid based Infant Formula
Commercially available Amino Acid Formulaother
Commercially available Amino Acid Formula